|Articles|April 16, 2020
Accelerated Enrollment Solutions Launches Patient-Transfer Program to Support Trial Continuity During COVID-19 Pandemic
Advertisement
Accelerated Enrollment Solutions (AES) has launched a program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemicby transferring clinical trial patients to AES’ dedicated research sites from other research facilities.
To find out more, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5